2024, Food and Drug Administration, Networking and Physicians

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2024

Food and Drug Administration

Networking

Physicians

FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis

Legacy MEDSearch

MARCH 1, 2024

Boston Scientific’s AGENT Drug-Coated Balloon (DCB) has been granted approval by the U.S. Food and Drug Administration (FDA) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. physicians the opportunity to treat their patients with this novel device.” Are you hiring?

Food and Drug Administration

Food and Drug Administration FDA Recruitment Patients

Exactech Announces FDA 510(k) Clearance for Advanced Activit-E™ Knee Replacement Polyethylene

Legacy MEDSearch

AUGUST 21, 2023

Food and Drug Administration for its new, advanced Activit-E polyethylene for the Truliant® knee replacement system. Global expansion will begin in 2024. The first products for Activit-E will launch in the beginning of Q3 2023 for select U.S. Headquartered in Gainesville, Fla.,

Food and Drug Administration

Food and Drug Administration FDA Recruitment Marketing

Webinars

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

MORE WEBINARS

Pharma Rep Focus

FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis

Exactech Announces FDA 510(k) Clearance for Advanced Activit-E™ Knee Replacement Polyethylene

Webinars

Stay Connected